{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:25:07Z","timestamp":1760235907943,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007783","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-202000000003326"],"award-info":[{"award-number":["HY-202000000003326"]}],"id":[{"id":"10.13039\/501100007783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: To evaluate the risk of non-vertebral fractures in patients with gout compared with those with rheumatoid arthritis (RA). Methods: Using claims data from Medicare (2008\u20132015), we conducted a cohort study of patients with gout versus RA matched on age, sex, and index date with a 1:1 ratio. The primary outcome was a composite endpoint of non-vertebral fractures including hip, pelvis, humerus, and wrist identified with the validated algorithms. We also assessed hip fractures separately. Multivariable Cox proportional hazards regression estimated the hazard ratio (HR) for the outcomes in gout versus RA adjusted for 45 covariates. Results: We included a total of 134,157 matched pairs of gout and RA patients (mean age: 73.7 years). Risk factors for fracture were more prevalent in RA, while other comorbidities including obesity, coronary heart disease, hypertension, and diabetes were more common in gout. Over the mean 2.8 years follow-up, the incidence rate (IR)\/1000 person-year (PY) of non-vertebral fractures was 10.42 in gout and 15.01 in RA. For hip fractures, the IR\/1000 PY was 4.86 in gout and 7.73 in RA. The multivariable HR associated with gout versus RA was 0.84 (95% confidence interval (CI) 0.80\u20130.88) for non-vertebral fractures and 0.76 (95% CI 0.71\u20130.82) for hip fractures. Stratified analyses by age, sex, prior fractures, steroid use, and TNF inhibitor use showed similar results. Conclusions: In this large cohort of older patients, gout was associated with a modestly decreased risk of non-vertebral or hip fractures versus RA. However, non-vertebral fractures occurred frequently in both gout and RA.<\/jats:p>","DOI":"10.3390\/jcm10204655","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T21:45:32Z","timestamp":1633988732000},"page":"4655","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid Arthritis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8837","authenticated-orcid":false,"given":"Soo-Kyung","family":"Cho","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02215, USA"},{"name":"Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinzhu","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-3579","authenticated-orcid":false,"given":"Seoyoung C.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02215, USA"},{"name":"Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/rheumatology\/ket001","article-title":"What can asymptomatic hyperuricaemia and systemic inflammation in the absence of gout tell us?","volume":"52","author":"Inaba","year":"2013","journal-title":"Rheumatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: Prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/ard.2009.109884","article-title":"Menopause, postmenopausal hormone use and risk of incident gout","volume":"69","author":"Hak","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans","volume":"67","author":"Singh","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-011-0234-2","article-title":"Association between gout and all-cause as well as cardiovascular mortality: A systematic review","volume":"14","author":"Lottmann","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","article-title":"Uric acid puzzle: Dual role as anti-oxidantand pro-oxidant","volume":"12","author":"Kang","year":"2014","journal-title":"Electrolyte Blood Press."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00198-014-2697-2","article-title":"Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: A longitudinal study using the National Claim Registry","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/BOR.0000000000000469","article-title":"Crystalline arthropathy and bone health","volume":"30","author":"Chang","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00198-017-4059-3","article-title":"The association between serum uric acid level and the risk of fractures: A systematic review and meta-analysis","volume":"28","author":"Yin","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","article-title":"The paradoxical relationship between serum uric acid and cardiovascular disease","volume":"392","author":"Lippi","year":"2008","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","article-title":"Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-\u03baB signaling pathway in HepG2 cells","volume":"37","author":"Spiga","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11914-012-0104-5","article-title":"Pathways for bone loss in inflammatory disease","volume":"10","author":"Braun","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of Osteoporosis: A mini-review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.semarthrit.2015.04.014","article-title":"Evolutionary medicine and bone loss in chronic inflammatory diseases\u2014A theory of inflammation-related osteopenia","volume":"45","author":"Straub","year":"2015","journal-title":"Semin. Arthr. Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2010.03.002","article-title":"Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis","volume":"77","author":"Blanchard","year":"2010","journal-title":"Jt. Bone Spine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2008.104786","article-title":"Interleukin-1 is essential for systemic inflammatory bone loss","volume":"69","author":"Polzer","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","article-title":"Biologic therapies and bone loss in rheumatoid arthritis","volume":"28","author":"Zerbini","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e6983","DOI":"10.1097\/MD.0000000000006983","article-title":"Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis","volume":"96","author":"Xue","year":"2017","journal-title":"Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3899\/jrheum.101196","article-title":"Arthritis increases the risk for fractures\u2014Results from the Women\u2019s Health Initiative","volume":"38","author":"Wright","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00296-016-3453-z","article-title":"Incidence and risk factors of fractures in patients with rheumatoid arthritis: An Asian prospective cohort study","volume":"36","author":"Kim","year":"2016","journal-title":"Rheumatol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-014-2968-y","article-title":"Rheumatoid arthritis patients with hip fracture: A nationwide study","volume":"26","author":"Lin","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e4669","DOI":"10.1097\/MD.0000000000004669","article-title":"Gout increases risk of fracture: A nationwide population-based cohort study","volume":"95","author":"Tzeng","year":"2016","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.39852","article-title":"Gout and risk of fracture in women: A prospective cohort study","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00264-018-4033-5","article-title":"Association of gout with osteoporotic fractures","volume":"42","author":"Wang","year":"2018","journal-title":"Int. Orthop."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jbmr.2978","article-title":"Gout and the Risk of Non-vertebral Fracture","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13018-019-1317-4","article-title":"Gout is not associated with the risk of fracture: A meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jbspin.2019.03.003","article-title":"Associations of hyperuricemia, gout, and UA-lowering therapy with the risk of fractures: A meta-analysis of observational studies","volume":"86","author":"Zong","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jclinepi.2012.10.004","article-title":"The validity of administrative data to identify hip fractures is high\u2014A systematic review","volume":"66","author":"Hudson","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","article-title":"Identification of fractures from computerized Medicare files","volume":"45","author":"Ray","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in medicare data: Development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun. Stat. Simul. Comput."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u2122 and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","article-title":"Energy regulation and neuroendocrine\u2013immune control in chronic inflammatory diseases","volume":"267","author":"Straub","year":"2010","journal-title":"J. Internal Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/20\/4655\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:11:44Z","timestamp":1760166704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/20\/4655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":36,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jcm10204655"],"URL":"https:\/\/doi.org\/10.3390\/jcm10204655","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}